110 related articles for article (PubMed ID: 23692545)
1. OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis.
Tugcu V; Simsek A; Tarhan T; Atalar F; Bitkin A; Tasci AI; Kural AR; Altug T
Ren Fail; 2013 Jul; 35(6):825-9. PubMed ID: 23692545
[TBL] [Abstract][Full Text] [Related]
2. Roles of osteopontin gene polymorphism (rs1126616), osteopontin levels in urine and serum, and the risk of urolithiasis: a meta-analysis.
Li X; Liu K; Pan Y; Zhang J; Lv Q; Hua L; Wang Z; Li J; Yin C
Biomed Res Int; 2015; 2015():315043. PubMed ID: 25785266
[TBL] [Abstract][Full Text] [Related]
3. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC; Huang SP; Tsai LY; Wu WJ; Juo SH; Chou YH; Huang CH; Wu MT
Clin Chim Acta; 2010 May; 411(9-10):739-43. PubMed ID: 20144595
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.
Chu M; Yang P; Hu R; Hou S; Li F; Chen Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7084-9. PubMed ID: 21810982
[TBL] [Abstract][Full Text] [Related]
5. Urinary concentration of osteopontin and association with urinary supersaturation and crystal formation.
Tsuji H; Tohru U; Hirotsugu U; Masanori I; Yuji H; Takashi K
Int J Urol; 2007 Jul; 14(7):630-4. PubMed ID: 17645608
[TBL] [Abstract][Full Text] [Related]
6. Association between the T-593A and C6982T polymorphisms of the osteopontin gene and risk of developing nephrolithiasis.
Gögebakan B; Igci YZ; Arslan A; Igci M; Erturhan S; Oztuzcu S; Sen H; Demiryürek S; Arikoglu H; Cengiz B; Bayraktar R; Yurtseven C; Sarıca K; Demiryürek AT
Arch Med Res; 2010 Aug; 41(6):442-8. PubMed ID: 21044748
[TBL] [Abstract][Full Text] [Related]
7. Analysis of osteopontin DNA in patients with urolithiasis.
Yamate T; Tsuji H; Amasaki N; Iguchi M; Kurita T; Kohri K
Urol Res; 2000 Jun; 28(3):159-66. PubMed ID: 10929424
[TBL] [Abstract][Full Text] [Related]
8. Association of Osteopontin Gene Polymorphisms with Colorectal Cancer.
Kamal A; Darwish RK; Saad S; Salama M; El-Baradie TS; Mahmoud HG; Elshiwy Y
Cancer Invest; 2017 Feb; 35(2):71-77. PubMed ID: 28095066
[TBL] [Abstract][Full Text] [Related]
9. Behçet's disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms.
Chu M; Yang P; Hou S; Li F; Chen Y; Kijlstra A
Hum Immunol; 2011 Jun; 72(6):525-9. PubMed ID: 21513757
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients.
Xu AP; Bai J; Lü J; Liang YY; Li JG; Lai DY; Wan X; Huang HH
Chin Med J (Engl); 2007 Dec; 120(23):2124-8. PubMed ID: 18167187
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.
Amar A; Afzal A; Hameed A; Ahmad M; Khan AR; Najma H; Abid A; Khaliq S
BMC Med Genet; 2020 Aug; 21(1):172. PubMed ID: 32842990
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin Gene Polymorphism and Urinary OPN Excretion in Patients with Immunoglobulin A Nephropathy.
Kaleta B; Krata N; Zagożdżon R; Mucha K
Cells; 2019 May; 8(6):. PubMed ID: 31159229
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin as a marker of weight loss in lung cancer.
Karadag F; Gulen ST; Karul AB; Kilicarslan N; Ceylan E; Kuman NK; Cildag O
Scand J Clin Lab Invest; 2011 Dec; 71(8):690-4. PubMed ID: 22017168
[TBL] [Abstract][Full Text] [Related]
14. The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma.
Fan Y; Zhang X; Yang ZH; Sun XW; Li SN; Zhong L; Cheng X; Wang Y; Ma YR
DNA Cell Biol; 2013 Oct; 32(10):594-600. PubMed ID: 23952692
[TBL] [Abstract][Full Text] [Related]
15. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
Kadoglou NP; Gerasimidis T; Golemati S; Kapelouzou A; Karayannacos PE; Liapis CD
J Vasc Surg; 2008 Jan; 47(1):55-62. PubMed ID: 18178454
[TBL] [Abstract][Full Text] [Related]
16. Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis.
Safarinejad MR; Shafiei N; Safarinejad S
Urolithiasis; 2013 Aug; 41(4):303-13. PubMed ID: 23784265
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.
Anan G; Yoneyama T; Noro D; Tobisawa Y; Hatakeyama S; Sutoh Yoneyama M; Yamamoto H; Imai A; Iwamura H; Kohada Y; Mikami J; Ito J; Kaiho Y; Yoneyama T; Hashimoto Y; Sato M; Ohyama C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877766
[TBL] [Abstract][Full Text] [Related]
18. The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis.
Lavi H; Assayag M; Schwartz A; Arish N; Fridlender ZG; Berkman N
PLoS One; 2017; 12(3):e0171945. PubMed ID: 28253271
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer.
Lee TY; Lin JT; Wu CC; Yu CC; Wu MS; Lee TC; Chen HP; Wu CY
J Clin Gastroenterol; 2013 Jul; 47(6):e55-9. PubMed ID: 23426449
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism.
Xu G; Sun W; He D; Wang L; Zheng W; Nie H; Ni L; Zhang D; Li N; Zhang J
J Rheumatol; 2005 Mar; 32(3):410-6. PubMed ID: 15742430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
